流式細胞術市場規模、份額和趨勢分析報告:按產品(儀器、軟件)、技術(基於珠子、基於細胞)、應用(工業、臨床)、最終用途、細分市場預測,2022- 2030年
市場調查報告書
商品編碼
1171056

流式細胞術市場規模、份額和趨勢分析報告:按產品(儀器、軟件)、技術(基於珠子、基於細胞)、應用(工業、臨床)、最終用途、細分市場預測,2022- 2030年

Flow Cytometry Market Size, Share & Trends Analysis Report By Product (Instruments, Software), By Technology (Bead-based, Cell-based), By Application (Industrial, Clinical), By End-use, And Segment Forecasts, 2022 - 2030

出版日期: | 出版商: Grand View Research | 英文 166 Pages | 商品交期: 2-10個工作天內

價格

流式細胞術市場增長和趨勢

根據 Grand View Research, Inc. 的一份新報告,到 2030 年,全球流式細胞術市場規模預計將達到 92.8 億美元,預測期內的複合年增長率為 7.07%。這項技術的進步正在引入新的和改進的分析工具,例如用於即時 (PoC) 測試的微流體流式細胞儀的開發。此外,癌症、免疫缺陷病和傳染病的患病率上升正在推動該行業的發展。此外,生物製藥、生命科學和生物技術研究活動的研發投資不斷增加,導致對流式細胞術儀器的需求增加。近年來,用於PoC檢測的便攜式微流控流式細胞儀的開發成為一個重要的焦點。

微流體和流式細胞術的結合為測量生物樣品的多種特性提供了有用的工具。例如,多種微流體和小型化檢測器的現成可用性使得基於微芯片的細胞儀的發展成為可能,包括光流控細胞儀、成像細胞儀和阻抗細胞儀。微流體流式細胞術設備的發展是有益的,因為它們具有成本效益、便攜和緊湊。此外,熒光染料的改進和台式細胞儀在學術研究環境中的實用性增加有望推動該行業的發展。

多色流式細胞術的發展正在加速該技術在藥物開發活動中的採用。例如,2020年1月,Beckman Coulter Life Sciences在歐洲推出了13色臨床流式細胞儀DxFLEX、CE-IVD。同樣,通過同時評估多個參數進行細胞分析的便利性使得此類儀器可廣泛用於合同研究目的。COVID-19 大流行也刺激了技術創新,這一領域的新產品發布就是證明。例如,2021 年 7 月,Metropolis Healthcare, Inc. 推出了 CoviRisk-TBNK,這是一種簡單的血液檢測,用於檢測住院 COVID-19 患者的風險狀態。

分析患者 ICU 設備和通風需求,以幫助減輕醫療資源壓力。該測試是一種基於流式細胞術的淋巴細胞亞群測定,已獲准用於體外診斷。此外,流式細胞術是免疫細胞計數和表徵的重要工具,可用於識別和驗證潛在的遺傳缺陷。該技術還用於觀察和監測幹細胞移植後患者的免疫反應,因此器官移植在推動該行業的增長方面發揮著關鍵作用。據世界衛生組織稱,全世界每年進行約 50,000 例幹細胞移植,預計這一數字在不久的將來還會增加,從而擴大該技術的應用範圍。

另一方面,技術先進的流式細胞術設備在一些新興國家可能負擔不起,因為設備非常昂貴。這些設備的成本可能高達 100,000 美元,這對中小型醫院和臨床實驗室來說是一個重大的預算限制。但像索尼這樣的製造商正在推出帶有軟件的新設備,可以自動執行許多流程。這樣的發展不僅會提高技術的可用性,而且有助於在不久的將來降低設備的平均成本(低於 100,000 美元)。

流式細胞儀市場報告亮點

到 2021 年,由於技術進步和慢性病的增加,設備產品部分將佔據最大份額。

基於細胞的流式細胞術技術在 2021 年主導行業,原因是對早期診斷的高需求以及對基於細胞的檢測的相關益處的日益認識

按應用劃分,由於流感、HIV 和 COVID-19 等傳染病的研發活動增加,臨床部門在 2021 年的銷售額中所佔份額最大。

由於學術機構和實驗室的研發活動增加,學術最終用戶部分在 2021 年引領市場

由於科學先進的流式細胞術解決方案的高采用率、高醫療保健支出和完善的醫療保健基礎設施,北美將在 2021 年成為市場領先的地區。

由於中國和印度等新興國家的製藥和生物技術行業的增長,亞太地區預計將在 2022 年至 2030 年實現最快的複合年增長率。

目錄

第一章 調查方法和範圍

  • 調查方法
  • 調查假設
  • 信息採購
    • 購買的數據庫
    • GVR內部數據庫
    • 次要信息
    • 初步調查
    • 初步調查詳情
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析(模型一)
      • 方法一:商品流動方法
    • 量價分析(模型二)
      • 方法二:量價分析
  • 二級信息列表
  • 目的
    • 流式細胞術市場的市場預測

第二章執行摘要

  • 市場快照
  • 段快照
  • 競爭格局的快照

3. 流式細胞術市場變量、趨勢和範圍

  • 市場系列展望
    • 母公司市場展望
    • 相關/子公司市場展望
  • 繪製滲透率和增長前景
    • 產品優先的關鍵機會
    • 技術優先的關鍵機會
    • 應用優先的關鍵機會
    • 最終用途優先考慮的關鍵機會
  • 市場動態
    • 市場驅動力分析
      • 慢性病和傳染病的流行
      • 對生物技術、臨床和生命科學研究的重大研發投資
      • 流式細胞術儀器和試劑的技術進步
      • 對即時診斷的需求不斷增長
    • 市場約束因素分析
      • 設備成本高
    • 市場挑戰
      • 低細胞吞吐率
  • 流式細胞術:一種市場分析工具
    • 行業分析 - 搬運工
    • 流式細胞術 - SWOT 分析,按因素(政治和法律,經濟和技術)
  • 監管和報銷場景
  • 價格分析
  • 交易數據
    • 流式細胞儀進出口國數據
  • COVID-19 影響分析

第四章產品經營分析

  • 流式細胞術市場:產品變化分析,2021 年和 2030 年
  • 樂器
    • 細胞分析儀
    • 細胞分選儀
  • 試劑和耗材
  • 軟件
  • 配件
  • 服務

第五章技術業務分析

  • 流式細胞術市場:技術波動分析,2021 年和 2030 年
  • 細胞基礎
  • 珠座

第六章應用業務分析

  • 流式細胞術市場:應用變化分析,2021 年和 2030 年
  • 研究
    • 藥品
      • 藥物發現
      • 體外毒性
      • 幹細胞
    • 凋亡
    • 細胞分選
    • 細胞週期分析
    • 免疫學
    • 細胞活力
  • 行業
  • 臨床
    • 癌症
    • 器官移植
    • 免疫缺陷
    • 血液學

第 7 章終端使用業務分析

  • 流式細胞術市場:最終用途變化分析,2021 年和 2030 年
  • 商業機構
    • 生物技術公司
    • 製藥公司
  • 醫院
  • 學術機構
  • 臨床實驗室

第八章區域業務分析

  • 流式細胞儀市場:區域差異分析
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 俄羅斯
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳大利亞
    • 新加坡
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國

第九章流式細胞儀市場競爭格局

  • 主要市場進入者的最新發展和影響分析
  • 公司分類
  • 供應商情況
    • 主要經銷商及渠道合作夥伴名單
  • 上市公司
    • 公司市場分析
    • 2021 年全球主要參與者市場份額分析
  • 民營企業
    • 主要初創企業名單
    • 公司市場分析
  • Regional Network Map
  • 公司簡介
    • DANAHER CORPORATION
      • 公司簡介
      • BioTek Instruments, Inc.
      • 公司簡介
      • Citiba
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • BECTON, DICKINSON AND COMPANY(BD)
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • SYSMEX CORPORATION
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • AGILENT TECHNOLOGIES, INC.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • APOGEE FLOW SYSTEMS LTD.
      • 公司簡介
      • 產品基準
      • 戰略舉措
    • BIO-RAD LABORATORIES, INC.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • THERMO FISHER SCIENTIFIC, INC.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • STRATEDIGM, INC.
      • 公司簡介
      • 產品基準
      • 戰略舉措
    • DIASORIN SPA
      • 公司簡介
      • Luminex Co., Ltd.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • MILTENYI BIOTEC
      • 公司簡介
      • 產品基準
      • 戰略舉措
    • SONY BIOTECHNOLOGY, INC.
      • 公司簡介
      • 產品基準
      • 戰略舉措
Product Code: GVR-1-68038-412-3

Flow Cytometry Market Growth & Trends:

The global flow cytometry market size is expected to reach USD 9.28 billion by 2030, registering a CAGR of 7.07% over the forecast period, according to a new report by Grand View Research, Inc. Technological advancements in the technique are introducing new and improved analytical tools, which include the development of microfluidic flow cytometry for Point-of-Care (PoC) testing. Furthermore, the rising prevalence of cancer, immunodeficiency disorders, and infectious diseases is driving the industry. In addition, increasing R&D investments in biopharmaceutical, life science, and biotechnology research activities have led to high demand for flow cytometry instruments.In recent years, a key focus has been on the development of portable microfluidic flow cytometry devices for PoC testing.

Microfluidics and flow cytometry together make a useful tool to measure multiple characteristics of biological samples. For instance, the easy availability of several microfluidics and miniaturized detectors have enabled the creation of microchip-based cytometers, such as optofluidic cytometer, imaging cytometer, and impedance cytometer. The development of microfluidic flow cytometry devices, which are cost-effective, portable, and compact, is beneficial. They are affordable in developing economies, such as Asia & Africa, and are enabling rapid growth in PoC testing applications.Furthermore, improvements in fluorescent dyes and the increasing utility of benchtop cytometers for academic research settings are expected to drive the industry.

Developments in multicolor flow cytometry are accelerating the adoption of the technique in novel drug development activities. For instance, in January 2020, DxFLEX, CE-IVD, a 13-colour clinical flow cytometry system was launched by Beckman Coulter Life Sciences in Europe. Similarly, easy cellular analysis by simultaneous evaluation of several parameters allows extensive use of such devices for contract research purposes.The COVID-19 pandemic also spurred innovations in the technique, as evidenced by the launch of new products in this domain. For instance, in July 2021, Metropolis Healthcare Ltd. launched CoviRisk-TBNK, a simple blood test to detect the risk status of a COVID-19 hospitalized patient.

It helps analyze patients' need for ICU facilities or ventilation and aids in the reduction of stress on healthcare resources. The test is a flow cytometry-based lymphocyte subset assay and is IVD-approved. Such innovations are anticipated to fuel industry growth in the near future.Moreover, flow cytometry is a significant tool in listing and characterizing immune cells, and is also helpful in recognizing and validating underlying genetic defects. The technique is also used to observe and monitor the immune response of patients after stem cell transplantation, and hence, organ transplantation plays an important role in boosting industry growth. According to the WHO, around 50,000 stem cell transplantations are performed globally every year, and this number is expected to grow in the near future, broadening the scope of applications for the technique.

On the other hand, instruments are highly expensive, and hence, buyers in several developing countries may not be able to afford technologically advanced flow cytometry equipment. These instruments may cost over USD 100,000 and pose significant budgetary constraints for small- & mid-sized hospitals and clinical laboratories. However, some manufacturers, such as Sony, are trying to launch newer instruments using software to automate a number of processes. Such developments would not only improve the usability of the technique but also help bring down the average instrumentation cost-under USD 100,000-in the near future.

Flow Cytometry Market Report Highlights:

  • The instrument product segment held the largest share in 2021 due to technical advancements, as well as increased prevalence of chronic conditions
  • Thecell-based flow cytometry technology dominated the industry in 2021 due to the high demand for early diagnosis and rising awareness about the associated benefits of cell-based assays
  • By application, the clinical segment accounted for the largest revenue share in 2021 owing to increasedR&D activities pertaining to infectious diseases, such as influenza, HIV, and COVID-19, among others
  • The academic institutes end-user segment led the market in 2021 owing to increased R&D activities by academic institutes & research centers
  • North America was theleadingregion in 2021due to the high implementation of scientifically advanced flow cytometry solutions, high healthcare expenditure, and well-established healthcare infrastructure in the region
  • Asia Pacific is expected to register the fastest CAGR from 2022 to 2030 owing to the extensive growth in the pharmaceutical and biotechnology industries in emerging economies, such as China and India

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Methodology
  • 1.2 Research Assumptions
    • 1.2.1 Estimates And Forecast Timeline
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
    • 1.6.2 Volume Price Analysis (Model 2)
      • 1.6.2.1 Approach 2: Volume Price Analysis
  • 1.7 List Of Secondary Sources
  • 1.8 Objectives
    • 1.8.1 Objective 1:
    • 1.8.2 Objective 2:
    • 1.8.3 Market Estimation For Flow Cytometry Market

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Flow Cytometry Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
    • 3.2.1 Key Opportunities Prioritized, By Product
    • 3.2.2 Key Opportunities Prioritized, By Technology
    • 3.2.3 Key Opportunities Prioritized, By Application
    • 3.2.4 Key Opportunities Prioritized, By End Use
  • 3.3 Market Dynamics
    • 3.3.1 Market Driver Analysis
      • 3.3.1.1 Growing Prevalence Of Chronic And Infectious Diseases
      • 3.3.1.2 High R&D Investments In Biotechnology, Clinical, And Life Science Research
      • 3.3.1.3 Technological Advancements In Flow Cytometry Instruments And Reagents
      • 3.3.1.4 Increasing Demand For Point-Of-Care Diagnostics
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 High Cost Of Instruments
    • 3.3.3 Market Challenges
      • 3.3.3.1 Low Cell Throughput Rate
  • 3.4 Flow Cytometry: Market Analysis Tools
    • 3.4.1 Industry Analysis - Porter's
    • 3.4.2 Flow Cytometry - Swot Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.5 Regulatory & Reimbursement Scenario
  • 3.6 Pricing Analysis
  • 3.7 Trade Data
    • 3.7.1 Import/Export Data For Flow Cytometers, By Country
  • 3.8 Covid-19 Impact Analysis

Chapter 4 Product Business Analysis

  • 4.1 Flow Cytometry Market: Product Movement Analysis, 2021 & 2030
  • 4.2 Instruments
    • 4.2.1 Global Instruments Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.2 Cell Analyzers
      • 4.2.2.1 Global Cell Analyzers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.3 Cell Sorters
      • 4.2.3.1 Global Cell Sorters Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.3 Reagents & Consumables
    • 4.3.1 Global Reagents & Consumables Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.4 Software
    • 4.4.1 Global Software Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.5 Accessories
    • 4.5.1 Global Accessories Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.6 Services
    • 4.6.1 Global Services Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5 Technology Business Analysis

  • 5.1 Flow Cytometry Market: Technology Movement Analysis, 2021 & 2030
  • 5.2 Cell-Based
    • 5.2.1 Global Cell-Based Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.3 Bead-Based
    • 5.3.1 Global Bead-Based Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6 Application Business Analysis

  • 6.1 Flow Cytometry Market: Application Movement Analysis, 2021 & 2030
  • 6.2 Research
    • 6.2.1 Global Research Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2 Pharmaceutical
      • 6.2.2.1 Global Pharmaceutical Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 6.2.2.2 Drug Discovery
      • 6.2.2.2.1 Global Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 6.2.2.3 In Vitro Toxicity
      • 6.2.2.3.1 Global In Vitro Toxicity Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 6.2.2.4 Stem Cell
      • 6.2.2.4.1 Global Stem Cell Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3 Apoptosis
      • 6.2.3.1 Global Apoptosis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4 Cell Sorting
      • 6.2.4.1 Global Cell Sorting Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.5 Cell Cycle Analysis
      • 6.2.5.1 Global Cell Cycle Analysis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.6 Immunology
      • 6.2.6.1 Global Immunology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.7 Cell Viability
      • 6.2.7.1 Global Cell Viability Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3 Industrial
    • 6.3.1 Global Industrial Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4 Clinical
    • 6.4.1 Global Clinical Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2 Cancer
      • 6.4.2.1 Global Cancer Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3 Organ Transplantation
      • 6.4.3.1 Global Organ Transplantation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4 Immunodeficiency
      • 6.4.4.1 Global Immunodeficiency Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5 Hematology
      • 6.4.5.1 Global Hematology Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7 End Use Business Analysis

  • 7.1 Flow Cytometry Market: End-Use Movement Analysis, 2021 & 2030
  • 7.2 Commercial Organizations
    • 7.2.1 Global Commercial Organizations Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2 Biotechnology Companies
      • 7.2.2.1 Global Biotechnology Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3 Pharmaceutical Companies
      • 7.2.3.1 Global Pharmaceutical Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4 CROS
      • 7.2.4.1 Global CROS Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.3 Hospitals
    • 7.3.1 Global Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4 Academic Institutes
    • 7.4.1 Global Academic Institutes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5 Clinical Testing Labs
    • 7.5.1 Global Clinical Testing Labs Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8 Regional Business Analysis

  • 8.1 Flow Cytometry Market: Regional Movement Analysis
  • 8.2 North America
    • 8.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.2 Germany
      • 8.3.2.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.3 U.K.
      • 8.3.3.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.4 France
      • 8.3.4.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.5 Italy
      • 8.3.5.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.6 Spain
      • 8.3.6.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.7 Russia
      • 8.3.7.1 Russia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.3 China
      • 8.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.4 India
      • 8.4.4.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.5 South Korea
      • 8.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.6 Australia
      • 8.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.7 Singapore
      • 8.4.7.1 Singapore Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.3 Mexico
      • 8.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.4 Argentina
      • 8.5.4.1 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.6 Middle East & Africa
    • 8.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.4 UAE
      • 8.6.4.1 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9 Flow Cytometry Market Competitive Landscape

  • 9.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2 Company Categorization
  • 9.3 Vendor Landscape
    • 9.3.1 List Of Key Distributors And Channel Partners
  • 9.4 Public Companies
    • 9.4.1 Company Market Position Analysis
    • 9.4.2 Global Key Company Market Share Analysis, 2021
  • 9.5 Private Companies
    • 9.5.1 List Of Key Emerging Companies
    • 9.5.2 Company Market Position Analysis
  • 9.6 Regional Network Map
  • 9.7 Company Profiles
    • 9.7.1 DANAHER CORPORATION
      • 9.7.1.1 Company overview
      • 9.7.1.2 Beckman Coulter, Inc.
      • 9.7.1.2.1 COMPANY OVERVIEW
      • 9.7.1.3 Cytiva
      • 9.7.1.3.1 COMPANY OVERVIEW
      • 9.7.1.4 Financial performance
      • 9.7.1.5 Product benchmarking
      • 9.7.1.6 Strategic initiatives
    • 9.7.2 BECTON, DICKINSON AND COMPANY (BD)
      • 9.7.2.1 Company overview
      • 9.7.2.2 Financial performance
      • 9.7.2.3 Product benchmarking
      • 9.7.2.4 Strategic initiatives
    • 9.7.3 SYSMEX CORPORATION
      • 9.7.3.1 Company overview
      • 9.7.3.2 Financial performance
      • 9.7.3.3 Product benchmarking
      • 9.7.3.4 Strategic initiatives
    • 9.7.4 AGILENT TECHNOLOGIES, INC.
      • 9.7.4.1 Company overview
      • 9.7.4.2 Financial performance
      • 9.7.4.3 Product benchmarking
      • 9.7.4.4 Strategic initiatives
    • 9.7.5 APOGEE FLOW SYSTEMS LTD.
      • 9.7.5.1 Company overview
      • 9.7.5.2 Product benchmarking
      • 9.7.5.3 Strategic initiatives
    • 9.7.6 BIO-RAD LABORATORIES, INC.
      • 9.7.6.1 Company overview
      • 9.7.6.2 Financial performance
      • 9.7.6.3 Product benchmarking
      • 9.7.6.4 Strategic initiatives
    • 9.7.7 THERMO FISHER SCIENTIFIC, INC.
      • 9.7.7.1 Company overview
      • 9.7.7.2 Financial performance
      • 9.7.7.3 Product benchmarking
      • 9.7.7.4 Strategic initiatives
    • 9.7.8 STRATEDIGM, INC.
      • 9.7.8.1 Company overview
      • 9.7.8.2 Product benchmarking
      • 9.7.8.3 Strategic initiatives
    • 9.7.9 DIASORIN S.P.A.
      • 9.7.9.1 Company overview
      • 9.7.9.2 Luminex Corporation
      • 9.7.9.2.1 COMPANY OVERVIEW
      • 9.7.9.3 Financial performance
      • 9.7.9.4 Product benchmarking
      • 9.7.9.5 Strategic initiatives
    • 9.7.10 MILTENYI BIOTEC
      • 9.7.10.1 Company overview
      • 9.7.10.2 Product benchmarking
      • 9.7.10.3 Strategic initiatives
    • 9.7.11 SONY BIOTECHNOLOGY, INC.
      • 9.7.11.1 Company overview
      • 9.7.11.2 Product benchmarking
      • 9.7.11.3 Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Regulatory status and recommended validation strategy for flow cytometry assays
  • Table 3 CPT codes for flow cytometry reimbursement
  • Table 4 Global flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 5 Global flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 6 Global flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 7 Global flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 8 Global flow cytometry market, by region, 2018 - 2030 (USD Million)
  • Table 9 North America flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 10 North America flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 11 North America flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 12 North America flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 13 North America flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 14 U.S. Flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 15 U.S. Flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 16 U.S. Flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 17 U.S. Flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 18 Canada flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 19 Canada flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 20 Canada flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 21 Canada flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 22 Europe flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 23 Europe flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 24 Europe flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 25 Europe flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 26 Europe flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 27 Germany flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 28 Germany flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 29 Germany flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 30 Germany flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 31 U.K. flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 32 U.K. flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 33 U.K. flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 34 U.K. flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 35 France flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 36 France flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 37 France flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 38 France flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 39 Italy flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 40 Italy flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 41 Italy flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 42 Italy flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 43 Spain flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 44 Spain flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 45 Spain flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 46 Spain flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 47 Russia flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 48 Russia flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Russia flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 50 Russia flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 51 Asia pacific flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 52 Asia pacific flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 53 Asia pacific flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 54 Asia pacific flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 55 Asia pacific flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 56 China flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 57 China flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 58 China flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 59 China flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 60 India flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 61 India flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 62 India flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 63 India flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 64 Japan flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 65 Japan flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 66 Japan flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 67 Japan flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 68 South Korea flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 69 South Korea flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 70 South Korea flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 71 South Korea flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 72 Australia flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 73 Australia flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Australia flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 75 Australia flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 76 Singapore flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 77 Singapore flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 78 Singapore flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 79 Singapore flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 80 Latin America flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 81 Latin America flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 82 Latin America flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 83 Latin America flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 84 Latin America flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 85 Brazil flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 86 Brazil flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 87 Brazil flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 88 Brazil flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 89 Mexico flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 90 Mexico flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 91 Mexico flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 92 Mexico flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 93 Argentina flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 94 Argentina flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 95 Argentina flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 96 Argentina flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 97 Middle east & Africa flow cytometry market, by country, 2018 - 2030 (USD Million)
  • Table 98 Middle east & Africa flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 99 Middle east & Africa flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 100 Middle east & Africa flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 101 Middle east & Africa flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 102 South Africa flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 103 South Africa flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 104 South Africa flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 105 South Africa flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 106 Saudi Arabia flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia flow cytometry market, end-use, 2018 - 2030 (USD Million)
  • Table 110 UAE flow cytometry market, by product, 2018 - 2030 (USD Million)
  • Table 111 UAE flow cytometry market, by technology, 2018 - 2030 (USD Million)
  • Table 112 UAE flow cytometry market, application, 2018 - 2030 (USD Million)
  • Table 113 UAE flow cytometry market, end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Commodity flow analysis
  • Fig. 10 Volume price analysis
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook (2021)
  • Fig. 15 Penetration & growth prospect mapping, by product
  • Fig. 16 Penetration & growth prospect mapping, by technology
  • Fig. 17 Penetration & growth prospect mapping, by application
  • Fig. 18 Penetration & growth prospect mapping, by end use
  • Fig. 19 Flow cytometry market driver impact
  • Fig. 20 Flow cytometry market restraint impact
  • Fig. 21 Porter's five force analysis
  • Fig. 22 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 23 Flow cytometers import shipments data (2022)
  • Fig. 24 Flow cytometers export shipments data (2022)
  • Fig. 25 Flow cytometry market: product outlook & key takeaways
  • Fig. 26 Flow cytometry market: product movement analysis
  • Fig. 27 Global instruments market, 2018 - 2030 (USD Million)
  • Fig. 28 Global cell analyzers market, 2018 - 2030 (USD Million)
  • Fig. 29 Global cell sorters market, 2018 - 2030 (USD Million)
  • Fig. 30 Global reagents & consumables market, 2018 - 2030 (USD Million)
  • Fig. 31 Global software market, 2018 - 2030 (USD Million)
  • Fig. 32 Global accessories market, 2018 - 2030 (USD Million)
  • Fig. 33 Global services market, 2018 - 2030 (USD Million)
  • Fig. 34 Flow cytometry market: technology outlook & key takeaways
  • Fig. 35 Flow cytometry market: technology movement analysis
  • Fig. 36 Global cell-based market, 2018 - 2030 (USD Million)
  • Fig. 37 Global bead-based market, 2018 - 2030 (USD Million)
  • Fig. 38 Flow cytometry market: application outlook & key takeaways
  • Fig. 39 Flow cytometry market: application movement analysis
  • Fig. 40 Global research application market, 2018 - 2030 (USD Million)
  • Fig. 41 Global pharmaceutical application market, 2018 - 2030 (USD Million)
  • Fig. 42 Global drug discovery application market, 2018 - 2030 (USD Million)
  • Fig. 43 Global in vitro toxicity application market, 2018 - 2030 (USD Million)
  • Fig. 44 Global stem cell application market, 2018 - 2030 (USD Million)
  • Fig. 45 Global apoptosis application market, 2018 - 2030 (USD Million)
  • Fig. 46 Global cell sorting application market, 2018 - 2030 (USD Million)
  • Fig. 47 Global cell cycle analysis application market, 2018 - 2030 (USD Million)
  • Fig. 48 Global immunology application market, 2018 - 2030 (USD Million)
  • Fig. 49 Global cell viability application market, 2018 - 2030 (USD Million)
  • Fig. 50 Global industrial application market, 2018 - 2030 (USD Million)
  • Fig. 51 Global clinical application market, 2018 - 2030 (USD Million)
  • Fig. 52 Global cancer application market, 2018 - 2030 (USD Million)
  • Fig. 53 Global organ transplantation application market, 2018 - 2030 (USD Million)
  • Fig. 54 Global immunodeficiency application market, 2018 - 2030 (USD Million)
  • Fig. 55 Global hematology application market, 2018 - 2030 (USD Million)
  • Fig. 56 Flow cytometry market: end use outlook & key takeaways
  • Fig. 57 Flow cytometry market: end use movement analysis
  • Fig. 58 Global commercial organizations market, 2018 - 2030 (USD Million)
  • Fig. 59 Global biotechnology companies market, 2018 - 2030 (USD Million)
  • Fig. 60 Global pharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 61 Global CROs market, 2018 - 2030 (USD Million)
  • Fig. 62 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 63 Global academic institutes market, 2018 - 2030 (USD Million)
  • Fig. 64 Global clinical testing labs market, 2018 - 2030 (USD Million)
  • Fig. 65 Regional marketplace: key takeaway
  • Fig. 66 Flow cytometry market: regional movement analysis
  • Fig. 67 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Russia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Singapore market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Heat map analysis, by key market participants
  • Fig. 93 Participant categorization - flow cytometry market
  • Fig. 94 Public company market position analysis, 2021
  • Fig. 95 Global key company market share analysis, 2021
  • Fig. 96 Private company market position analysis, 2021
  • Fig. 97 Regional network map